FDA Approves Supplement for Gadobutrol by Hengrui Pharma
The FDA has approved a supplemental application for Gadobutrol submitted by Hengrui Pharma.
Asset / Drug
Drug and asset intelligence for Gadobutrol with 5 indexed intelligence signals across regulatory, clinical, competitive, and market developments.
The FDA has granted approval for the ANDA219287 application for Gadobutrol submitted by Viwit Pharm.
No catalysts indexed for this entity yet.
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.